This implies that passive immunization with tau antibodies is a practical therapeutic target and the CSF volume of p-tau262/356 or of your microtubule binding domain (MTBD) can serve as a beneficial biomarker of tau pathology to observe tau therapeutics in medical trials.They then seeded these cell lines with fibrils from 8 Advertisement, 5 CBD, tw